[HTML][HTML] FDA approval of aduhelm paves a new path for Alzheimer's disease
RE Tanzi - ACS chemical neuroscience, 2021 - ACS Publications
Aduhelm is an immunotherapy from Biogen that induces clearance of Alzheimer, s disease
(AD)-associated βamyloid deposits in the brain. Aduhelm was originally developed at the …
(AD)-associated βamyloid deposits in the brain. Aduhelm was originally developed at the …
[引用][C] FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease.
RE Tanzi - ACS Chemical Neuroscience, 2021 - europepmc.org
FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
[引用][C] FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease
RE Tanzi - ACS chemical neuroscience, 2021 - pubmed.ncbi.nlm.nih.gov